$Dear Sir or Madam
Facing ongoing competitive pressures and market growth demands, life science and biomedical OEMs must constantly deliver new advancements in technology, processes, workflows, and production.
But in addition to pursuing improvements that focus on expanding success, OEMs must also ensure against in-use failures of their advanced equipment. In the case of advanced instruments utilized in research, scientific, medical, and other critical applications, neglecting improvements and safeguards in one seemingly minor component — in-process linear motion systems — can generate consequences ranging from inconvenient to catastrophic.
A new white paper details how next-generation linear motion systems can be specified, designed, installed, and maintained to advance life science and biomedical capital equipment manufacturing — and ensure against failures of any consequence. | 
